CF organoid systems not only enable functional modeling of mutant CFTR (cystic fibrosis transmembrane conductance regulator) dysfunction but also serve as essential experimental platforms for investigating the mechanisms of CF-related complications in organs such as the biliary tract and for exploring targeted interventions. The gene discussed is CFTR; the disease is cystic fibrosis.